The Novel Methylation Biomarker NPY5R Sensitizes Breast Cancer Cells to Chemotherapy

Overview of attention for article published in Frontiers in Cell and Developmental Biology, January 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,784 followers.

The Novel Methylation Biomarker NPY5R Sensitizes Breast Cancer Cells to Chemotherapy. https://t.co/pzyhlVFXKx

29 Jan 2022

Reply Repost Favourite

The Novel Methylation Biomarker NPY5R Sensitizes Breast Cancer Cells to Chemotherapy https://t.co/MMs9TX1Xeg

28 Jan 2022

Reply Repost Favourite

New Research: The Novel Methylation Biomarker NPY5R Sensitizes Breast Cancer Cells to Chemotherapy: Breast cancer (BC) is the most common tumor in women, and the molecular mechanism underlying its pathogenesis remains unclear. In this study,… https://t.co/

12 Jan 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.